Apotex paid Sanofi and Bristol-Myers $445 million
08 February 2012
Simon Crompton, London
Sanofi’s annual results have revealed that generic rival Apotex paid it and partner Bristol-Myers Squibb over $445 million to settle a dispute over blockbuster drug Plavix
The French pharmaceutical company’s results were released earlier today. They show that Apotex paid the fee following a ruling in the US that the patent for blood thinner Plavix was valid.
Apotex launched a rival, generic version of Plavix in 2006 in an attempt...
Only subscribers have complete access to Managing Internet IP,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing Internet IP (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial